LONDON: Smith+Nephew, the global medical technology company, announced that it has completed the acquisition of CartiHeal, developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee. Agili-C is an off-the-shelf one-step treatment for osteochondral (bone and…
LONDON, UK: Smith+Nephew, the global medical technology company, has entered into a definitive agreement to acquire CartiHeal, developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee, a statement said. Under the terms of the agreement,…
LONDON, UK: Smith+Nephew, the global medical technology business listed on the LSE and NYSE, has announced that John Rogers will take over as Chief Financial Officer (CFO) from Anne-Françoise Nesmes. Rogers will join the company as CFO-designate on December 1,…
LONDON, UK: Smith+Nephew (LSE:SN, NYSE:SNN) announced Dr Deepak Nath has been appointed as the Company’s new Chief Executive Officer (CEO), succeeding Roland Diggelmann, who will step down by mutual agreement. Deepak will take up the role on 1 April 2022 and Roland will…
LONDON, UK: Smith+Nephew, the global medical technology business, announced the acquisition of Engage Surgical, owner of the only cementless unicompartmental (partial) knee system commercially available in the US. This acquisition strongly supports Smith+Nephew’s strategy for growth by transforming its business…
LONDON: Smith+Nephew, the global medical technology business, has agreed to acquire the Extremity Orthopaedics business of Integra LifeSciences Holdings Corporation for $240 million, a news release said. This acquisition will significantly strengthen Smith+Nephew’s extremities business by adding a combination of…